联合FDG PET/MRI与标准诊疗影像在心脏结节病评估中的比较
前瞻性连续纳入40例疑似心脏结节病患者,同日行联合心脏18F-FDG PET/MRI与标准诊疗影像(心脏MRI、18F-FDG PET/CT及SPECT灌注显像)平行评估。联合PET/MRI总辐射剂量降低52%(8.0 mSv ± 1.2 vs 16.8 mSv ± 1.6,P < .001),总成像时间缩短43%(122分钟 ± 15 vs 214分钟 ± 26,P < .001),诊断心脏结节病的AUC最高(0.84),FDG摄取与晚期钆增强共定位且呈典型心脏结节病模式时特异度96%、敏感度71%。
要点
- 联合心脏18F-FDG PET/MRI诊断心脏结节病AUC为0.84,FDG摄取与晚期钆增强共定位呈典型模式时特异度96%、敏感度71%。
- 联合PET/MRI较标准诊疗影像总辐射剂量降低52%(8.0 mSv ± 1.2 vs 16.8 mSv ± 1.6,P < .001)。
- 联合PET/MRI较标准诊疗影像总成像时间缩短43%(122分钟 ± 15 vs 214分钟 ± 26,P < .001)。
核心结论
- 在疑似心脏结节病评估中,联合心脏18F-FDG PET/MRI较标准诊疗影像辐射剂量更低、成像时间更短、诊断效能更高。
研究设计与样本
- 前瞻性研究于2017年11月至2021年5月连续纳入40例疑似心脏结节病患者,同日行联合心脏18F-FDG PET/MRI与心脏18F-FDG PET/CT及门控静息99mTc-司他比SPECT灌注显像平行评估(ClinicalTrials.gov NCT03356756),最终诊断依据日本厚生劳动省指南。
关键影像表现/征象
- MRI表现先在不结合PET数据的情况下判读,随后将PET与晚期钆增强图像融合并共同判读。
- 联合PET/MRI诊断心脏结节病的AUC为0.84,FDG摄取与晚期钆增强共定位且呈典型心脏结节病模式时特异度96%、敏感度71%。
诊断标准与关键数值
- 心脏结节病最终诊断采用日本厚生劳动省指南标准。
- FDG摄取与晚期钆增强共定位且呈典型心脏结节病模式时,联合PET/MRI诊断心脏结节病的特异度96%、敏感度71%,AUC 0.84。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare combined cardiac fluorine 18 (18F) fluorodeoxyglucose (FDG) PET/MRI with standard-of-care evaluation using cardiac MRI, 18F-FDG PET/CT, and SPECT perfusion imaging in suspected cardiac sarcoidosis (CS) with respect to radiation dose, imaging duration, and diagnostic test performance.
MATERIALS AND METHODS: Consecutive patients with suspected CS undergoing clinical evaluation with cardiac 18F-FDG PET/CT and gated rest technetium 99m sestamibi SPECT perfusion imaging were prospectively recruited between November 2017 and May 2021 for parallel assessment with combined cardiac 18F-FDG PET/MRI on the same day (ClinicalTrials.gov identifier, NCT03356756). Total effective radiation dose and imaging duration were compared between approaches (combined cardiac PET/MRI vs separate cardiac MRI, PET/CT, and SPECT). MRI findings were initially interpreted without PET data, and then PET and late gadolinium enhancement images were fused and interpreted together. Final diagnosis of CS was established using Japanese Ministry of Health and Welfare guidelines.
RESULTS: Forty participants (mean age, 54 years ± 14 [SD]; 26 [65%] male participants) were included, 14 (35%) with a final diagnosis of CS. Compared with separate cardiac MRI, PET/CT, and SPECT perfusion imaging, combined cardiac PET/MRI had 52% lower total radiation dose (8.0 mSv ± 1.2 vs 16.8 mSv ± 1.6, P < .001) and 43% lower total imaging duration (122 minutes ± 15 vs 214 minutes ± 26, P < .001). Combined PET/MRI had the highest area under the curve for diagnosis of CS (0.84) with 96% specificity and 71% sensitivity for colocalized FDG uptake and late gadolinium enhancement in a pattern typical for CS.
CONCLUSION: In the evaluation of suspected CS, combined cardiac 18F-FDG PET/MRI had a lower radiation dose, shorter imaging duration, and higher diagnostic performance compared with standard-of-care imaging.Clinical trial registration no. NCT03356756Keywords: Cardiac Sarcoidosis, 18F-FDG PET/MRI, 18F-FDG PET/CT, SPECT Perfusion Imaging, Cardiac MRI, Standard-of-Care Imaging Supplemental material is available for this article. © RSNA, 2023.
引用
- Marschner CA, Aloufi F, Aitken M, et al. Combined FDG PET/MRI versus Standard-of-Care Imaging in the Evaluation of Cardiac Sarcoidosis. Radiol Cardiothorac Imaging. 2023. PMID: 38076597. doi:10.1148/ryct.220292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。